BMEZETF / FundBlackRock Health Sciences Term Trust
Verdicts genuinely change. Free email alert the moment BMEZ's does — no target price to set, unlike "Alert" above.
Whether this fund clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
BlackRock Health Sciences Term Trust
175 holdings · as of 2026-06-30 (4.0 months ago) The fund may have traded since. SEC Form N-PORT is filed quarterly and lags the period it covers, so these are the most recent holdings on file, not the fund’s holdings today.
NON-COMPLIANT 18.24% of portfolio weight is in non-compliant holdings, over the 5% threshold.
175 holdings, 100 matched (74% of weight). Portfolio as of 2026-06-30, filed 2026-08-25. Source: SEC Form N-PORT.
3.99% of this portfolio’s income is non-permissible — weighted across holdings, computed over 67% of portfolio weight (79 of 175 holdings). The common approach purifies that proportion of income received — dividends — not of the position’s value. We report the ratio; what to do with it is a question for your own scholar.
56.3% compliant 0.0% questionable 18.2% non-compliant 25.6% unscreened
All holdings (175)
| Holding | Status | Weight | Every methodology, and the debt ratio behind it |
|---|---|---|---|
| MRNA Moderna Inc | NON_COMPLIANT | 3.57% | AAOIFI2.2% Usmani11.7% Dow Jones Islamic7.4% S&P Shariah5.1% MSCI Islamic11.4% MSCI Islamic M-Series5.1% FTSE Shariah5.4% |
| JNJ Johnson & Johnson | COMPLIANT | 3.43% | AAOIFI7.6% Usmani24.4% Dow Jones Islamic10.9% S&P Shariah11.7% MSCI Islamic24.4% MSCI Islamic M-Series11.7% FTSE Shariah24.4% |
| MRK Merck & Co Inc | COMPLIANT | 3.01% | AAOIFI14.7% Usmani41.5% Dow Jones Islamic21.8% S&P Shariah20.9% MSCI Islamic41.5% MSCI Islamic M-Series20.9% FTSE Shariah41.5% |
| BIIB Biogen Inc | COMPLIANT | 2.76% | AAOIFI21.2% Usmani22.5% Dow Jones Islamic27.5% S&P Shariah24.3% MSCI Islamic22.5% MSCI Islamic M-Series24.3% FTSE Shariah21.3% |
| PsiQuantum Corp | UNSCREENED | 2.56% | no in-house ratios for this holding |
| GILD Gilead Sciences Inc | COMPLIANT | 2.52% | AAOIFI14.4% Usmani53.2% Dow Jones Islamic18.6% S&P Shariah21.4% MSCI Islamic53.2% MSCI Islamic M-Series21.4% FTSE Shariah53.2% |
| EW Edwards Lifesciences Corp | COMPLIANT | 2.33% | AAOIFI1.4% Usmani5.1% Dow Jones Islamic1.5% S&P Shariah1.5% MSCI Islamic5.1% MSCI Islamic M-Series1.5% FTSE Shariah4.3% |
| NBIX Neurocrine Biosciences Inc | COMPLIANT | 1.99% | AAOIFI2.9% Usmani8.6% Dow Jones Islamic3.4% S&P Shariah3.5% MSCI Islamic8.6% MSCI Islamic M-Series3.5% FTSE Shariah0.0% |
| NVS Novartis AG | COMPLIANT | 1.98% | AAOIFI12.5% Usmani25.9% Dow Jones Islamic11.8% S&P Shariah12.6% MSCI Islamic25.9% MSCI Islamic M-Series12.6% FTSE Shariah25.9% |
| AMGN Amgen Inc | COMPLIANT | 1.92% | AAOIFI24.9% Usmani59.9% Dow Jones Islamic33.6% S&P Shariah35.1% MSCI Islamic59.9% MSCI Islamic M-Series35.1% FTSE Shariah59.9% |
| ILMN Illumina Inc | COMPLIANT | 1.90% | AAOIFI1.6% Usmani8.1% Dow Jones Islamic2.7% S&P Shariah2.7% MSCI Islamic8.1% MSCI Islamic M-Series2.7% FTSE Shariah0.0% |
| RO.SW Roche Holding AG | COMPLIANT | 1.77% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| TMO Thermo Fisher Scientific Inc | COMPLIANT | 1.62% | AAOIFI20.5% Usmani40.3% Dow Jones Islamic23.4% S&P Shariah22.9% MSCI Islamic40.3% MSCI Islamic M-Series22.9% FTSE Shariah40.3% |
| ABBV AbbVie Inc | COMPLIANT | 1.59% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail |
| GMAB.CO Genmab A/S | COMPLIANT | 1.48% | AAOIFIpass Usmanifail Dow Jones Islamicfail S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail |
| AXSM Axsome Therapeutics Inc | COMPLIANT | 1.43% | AAOIFI1.9% Usmani29.5% Dow Jones Islamic2.9% S&P Shariah3.5% MSCI Islamic27.6% MSCI Islamic M-Series3.5% FTSE Shariah24.7% |
| DHR Danaher Corp | COMPLIANT | 1.40% | AAOIFI18.2% Usmani28.8% Dow Jones Islamic17.7% S&P Shariah16.7% MSCI Islamic28.8% MSCI Islamic M-Series16.7% FTSE Shariah28.8% |
| A Agilent Technologies Inc | COMPLIANT | 1.39% | AAOIFI9.3% Usmani28.3% Dow Jones Islamic10.8% S&P Shariah10.7% MSCI Islamic28.3% MSCI Islamic M-Series10.7% FTSE Shariah28.3% |
| NTRA Natera Inc | COMPLIANT | 1.31% | AAOIFI0.5% Usmani9.0% Dow Jones Islamic0.9% S&P Shariah1.2% MSCI Islamic9.0% MSCI Islamic M-Series1.2% FTSE Shariah3.0% |
| BlackRock Liquidity Funds | UNSCREENED | 1.30% | no in-house ratios for this holding |
| CYTK Cytokinetics Inc | NON_COMPLIANT | 1.29% | AAOIFI3.9% Usmani20.7% Dow Jones Islamic5.9% S&P Shariah6.2% MSCI Islamic20.7% MSCI Islamic M-Series6.2% FTSE Shariah14.3% |
| CRL Charles River Laboratories International Inc | COMPLIANT | 1.28% | AAOIFI21.2% Usmani40.3% Dow Jones Islamic33.1% S&P Shariah30.9% MSCI Islamic40.3% MSCI Islamic M-Series30.9% FTSE Shariah34.9% |
| UNH UnitedHealth Group Inc | NON_COMPLIANT | 1.27% | AAOIFI20.4% Usmani23.7% Dow Jones Islamic20.4% S&P Shariah18.8% MSCI Islamic23.7% MSCI Islamic M-Series18.8% FTSE Shariah23.7% |
| GSK GSK PLC | COMPLIANT | 1.27% | AAOIFI19.2% Usmani23.6% Dow Jones Islamic10.6% S&P Shariah11.2% MSCI Islamic23.6% MSCI Islamic M-Series11.2% FTSE Shariah23.6% |
| GH Guardant Health Inc | COMPLIANT | 1.25% | AAOIFI7.8% Usmani88.7% Dow Jones Islamic17.9% S&P Shariah23.1% MSCI Islamic88.7% MSCI Islamic M-Series23.1% FTSE Shariah78.6% |
| UCB.BR UCB SA | COMPLIANT | 1.23% | AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| Revolution Medicines Inc | UNSCREENED | 1.21% | no in-house ratios for this holding |
| Sartorius AG | UNSCREENED | 1.15% | no in-house ratios for this holding |
| ADARX PHARMACEUTICALS INC | UNSCREENED | 1.13% | no in-house ratios for this holding |
| TECH Bio-Techne Corp | COMPLIANT | 1.11% | AAOIFI2.5% Usmani11.2% Dow Jones Islamic3.0% S&P Shariah2.9% MSCI Islamic11.2% MSCI Islamic M-Series2.9% FTSE Shariah7.7% |
| DXCM Dexcom Inc | COMPLIANT | 1.08% | AAOIFI4.1% Usmani21.7% Dow Jones Islamic4.7% S&P Shariah4.0% MSCI Islamic20.9% MSCI Islamic M-Series4.0% FTSE Shariah19.3% |
| EXEL Exelixis Inc | COMPLIANT | 1.06% | AAOIFI1.2% Usmani6.7% Dow Jones Islamic1.5% S&P Shariah1.7% MSCI Islamic6.7% MSCI Islamic M-Series1.7% FTSE Shariah0.0% |
| IMCR Immunocore Holdings PLC | NON_COMPLIANT | 1.06% | AAOIFI24.8% Usmani42.8% Dow Jones Islamic29.4% S&P Shariah24.5% MSCI Islamic42.8% MSCI Islamic M-Series24.5% FTSE Shariah39.2% |
| RYTM Rhythm Pharmaceuticals Inc | NON_COMPLIANT | 1.05% | AAOIFI1.8% Usmani25.1% Dow Jones Islamic2.0% S&P Shariah2.4% MSCI Islamic25.1% MSCI Islamic M-Series2.4% FTSE Shariah24.3% |
| ARGX Argenx SE | COMPLIANT | 1.03% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| AZN AstraZeneca PLC | COMPLIANT | 1.02% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| PFE Pfizer Inc | NON_COMPLIANT | 0.99% | AAOIFI39.8% Usmani31.4% Dow Jones Islamic46.1% S&P Shariah45.9% MSCI Islamic31.4% MSCI Islamic M-Series45.9% FTSE Shariah31.4% |
| VRTX Vertex Pharmaceuticals Inc | COMPLIANT | 0.96% | AAOIFI1.6% Usmani7.2% Dow Jones Islamic1.7% S&P Shariah1.7% MSCI Islamic7.2% MSCI Islamic M-Series1.7% FTSE Shariah0.0% |
| BMY Bristol-Myers Squibb Co | NON_COMPLIANT | 0.95% | AAOIFI37.3% Usmani51.1% Dow Jones Islamic42.2% S&P Shariah44.8% MSCI Islamic51.1% MSCI Islamic M-Series44.8% FTSE Shariah48.9% |
| BSX Boston Scientific Corp | COMPLIANT | 0.95% | AAOIFI19.4% Usmani27.9% Dow Jones Islamic10.0% S&P Shariah10.9% MSCI Islamic27.9% MSCI Islamic M-Series10.9% FTSE Shariah27.9% |
| GENESIS THERAPEUTICS INC | UNSCREENED | 0.94% | no in-house ratios for this holding |
| IQV IQVIA Holdings Inc | NON_COMPLIANT | 0.84% | AAOIFI36.7% Usmani55.2% Dow Jones Islamic47.8% S&P Shariah44.8% MSCI Islamic54.4% MSCI Islamic M-Series44.8% FTSE Shariah53.4% |
| ALKS Alkermes PLC | COMPLIANT | 0.81% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| Cogent Biosciences Inc | UNSCREENED | 0.80% | no in-house ratios for this holding |
| Roivant Sciences Ltd | UNSCREENED | 0.79% | no in-house ratios for this holding |
| PTGX Protagonist Therapeutics Inc | NON_COMPLIANT | 0.78% | AAOIFI0.1% Usmani1.0% Dow Jones Islamic0.2% S&P Shariah0.3% MSCI Islamic1.0% MSCI Islamic M-Series0.3% FTSE Shariah0.0% |
| LONN.SW Lonza Group AG | COMPLIANT | 0.75% | AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| LARONDE INC | UNSCREENED | 0.75% | no in-house ratios for this holding |
| NUMAB THERAPEUTICS AG | UNSCREENED | 0.75% | no in-house ratios for this holding |
| 4523.T Eisai Co Ltd | COMPLIANT | 0.71% | AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| KARTOS THERAPEUTICS INC | UNSCREENED | 0.70% | no in-house ratios for this holding |
| Apogee Therapeutics Inc | UNSCREENED | 0.69% | no in-house ratios for this holding |
| ISRG Intuitive Surgical Inc | COMPLIANT | 0.67% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| Teva Pharmaceutical Industries Ltd | UNSCREENED | 0.67% | no in-house ratios for this holding |
| MBX Biosciences Inc | UNSCREENED | 0.66% | no in-house ratios for this holding |
| LB Pharmaceuticals Inc | UNSCREENED | 0.63% | no in-house ratios for this holding |
| GALDY Galderma Group AG | COMPLIANT | 0.62% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| Nuvalent Inc | UNSCREENED | 0.60% | no in-house ratios for this holding |
| ABT Abbott Laboratories | COMPLIANT | 0.58% | AAOIFI19.2% Usmani31.9% Dow Jones Islamic17.6% S&P Shariah18.3% MSCI Islamic31.9% MSCI Islamic M-Series18.3% FTSE Shariah30.8% |
| Oruka Therapeutics Inc | UNSCREENED | 0.57% | no in-house ratios for this holding |
| Dianthus Therapeutics Inc | UNSCREENED | 0.56% | no in-house ratios for this holding |
| RCUS Arcus Biosciences Inc | COMPLIANT | 0.56% | AAOIFI4.0% Usmani12.3% Dow Jones Islamic5.6% S&P Shariah6.2% MSCI Islamic12.3% MSCI Islamic M-Series6.2% FTSE Shariah10.9% |
| GSK GSK PLC | COMPLIANT | 0.55% | AAOIFI19.2% Usmani23.6% Dow Jones Islamic10.6% S&P Shariah11.2% MSCI Islamic23.6% MSCI Islamic M-Series11.2% FTSE Shariah23.6% |
| KLRA KAILERA THERAPEUTICS INC | NON_COMPLIANT | 0.51% | AAOIFI0.5% Usmani0.8% Dow Jones Islamic— S&P Shariah— MSCI Islamic0.8% MSCI Islamic M-Series— FTSE Shariah0.0% |
| EVERLY WELL INC | UNSCREENED | 0.50% | no in-house ratios for this holding |
| INSITRO INC | UNSCREENED | 0.50% | no in-house ratios for this holding |
| LNTH Lantheus Holdings Inc | COMPLIANT | 0.50% | AAOIFI1.9% Usmani5.2% Dow Jones Islamic2.2% S&P Shariah2.3% MSCI Islamic5.2% MSCI Islamic M-Series2.3% FTSE Shariah2.9% |
| NIKANG THERAPEUTICS INC | UNSCREENED | 0.50% | no in-house ratios for this holding |
| WAT Waters Corp | COMPLIANT | 0.49% | AAOIFI14.1% Usmani21.2% Dow Jones Islamic21.2% S&P Shariah23.3% MSCI Islamic21.2% MSCI Islamic M-Series23.3% FTSE Shariah19.7% |
| ELAN Elanco Animal Health Inc | NON_COMPLIANT | 0.48% | AAOIFI31.2% Usmani27.5% Dow Jones Islamic41.7% S&P Shariah45.2% MSCI Islamic27.5% MSCI Islamic M-Series45.2% FTSE Shariah27.5% |
| BEAM Beam Therapeutics Inc | NON_COMPLIANT | 0.48% | AAOIFI8.2% Usmani17.8% Dow Jones Islamic10.4% S&P Shariah10.7% MSCI Islamic17.8% MSCI Islamic M-Series10.7% FTSE Shariah7.2% |
| BIO Bio-Rad Laboratories Inc | COMPLIANT | 0.48% | AAOIFI9.3% Usmani9.5% Dow Jones Islamic11.8% S&P Shariah11.6% MSCI Islamic9.5% MSCI Islamic M-Series11.6% FTSE Shariah7.8% |
| 2269.HK Wuxi Biologics Cayman Inc | COMPLIANT | 0.48% | AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahpass |
| HALO Halozyme Therapeutics Inc | COMPLIANT | 0.46% | AAOIFI17.2% Usmani83.3% Dow Jones Islamic27.4% S&P Shariah30.4% MSCI Islamic83.3% MSCI Islamic M-Series30.4% FTSE Shariah83.3% |
| Quanta Dialysis Technologies Ltd | UNSCREENED | 0.44% | no in-house ratios for this holding |
| INCY Incyte Corp | COMPLIANT | 0.43% | AAOIFI0.1% Usmani0.7% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.3% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| ALC Alcon AG | COMPLIANT | 0.41% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| STOK Stoke Therapeutics Inc | NON_COMPLIANT | 0.40% | AAOIFI0.1% Usmani0.7% Dow Jones Islamic0.2% S&P Shariah0.3% MSCI Islamic0.7% MSCI Islamic M-Series0.3% FTSE Shariah0.0% |
| MIRVIE INC | UNSCREENED | 0.38% | no in-house ratios for this holding |
| KNSA Kiniksa Pharmaceuticals International Plc | COMPLIANT | 0.38% | AAOIFI0.2% Usmani1.1% Dow Jones Islamic0.3% S&P Shariah0.4% MSCI Islamic1.1% MSCI Islamic M-Series0.4% FTSE Shariah0.0% |
| ORNA THERAPEUTICS HOLDINGS LLC | UNSCREENED | 0.38% | no in-house ratios for this holding |
| BRKR Bruker Corp | COMPLIANT | 0.36% | AAOIFI18.9% Usmani30.1% Dow Jones Islamic25.7% S&P Shariah22.6% MSCI Islamic30.1% MSCI Islamic M-Series22.6% FTSE Shariah30.1% |
| Insmed Inc | UNSCREENED | 0.36% | no in-house ratios for this holding |
| Relay Therapeutics Inc | UNSCREENED | 0.32% | no in-house ratios for this holding |
| PODD Insulet Corp | COMPLIANT | 0.30% | AAOIFI9.6% Usmani30.0% Dow Jones Islamic5.3% S&P Shariah5.9% MSCI Islamic30.0% MSCI Islamic M-Series5.9% FTSE Shariah30.0% |
| Palvella Therapeutics Inc | UNSCREENED | 0.30% | no in-house ratios for this holding |
| NTLA Intellia Therapeutics Inc | NON_COMPLIANT | 0.30% | AAOIFI4.1% Usmani8.6% Dow Jones Islamic5.1% S&P Shariah4.1% MSCI Islamic8.6% MSCI Islamic M-Series4.1% FTSE Shariah0.0% |
| NVCR Novocure Ltd | NON_COMPLIANT | 0.30% | AAOIFI13.9% Usmani29.2% Dow Jones Islamic12.6% S&P Shariah12.9% MSCI Islamic29.2% MSCI Islamic M-Series12.9% FTSE Shariah24.5% |
| Viridian Therapeutics Inc | UNSCREENED | 0.30% | no in-house ratios for this holding |
| Angitia Biopharmaceuticals Limited | UNSCREENED | 0.27% | no in-house ratios for this holding |
| Erasca Inc | UNSCREENED | 0.27% | no in-house ratios for this holding |
| RadNet Inc | UNSCREENED | 0.27% | no in-house ratios for this holding |
| AGIO Agios Pharmaceuticals Inc | NON_COMPLIANT | 0.27% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| Alumis Inc | UNSCREENED | 0.27% | no in-house ratios for this holding |
| BlackRock Funds III | UNSCREENED | 0.26% | no in-house ratios for this holding |
| PTCT PTC Therapeutics Inc | NON_COMPLIANT | 0.26% | AAOIFI11.9% Usmani21.4% Dow Jones Islamic16.9% S&P Shariah20.0% MSCI Islamic21.2% MSCI Islamic M-Series20.0% FTSE Shariah18.2% |
| Enliven Therapeutics Inc | UNSCREENED | 0.26% | no in-house ratios for this holding |
| BBIO Bridgebio Pharma Inc | COMPLIANT | 0.25% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| IONS Ionis Pharmaceuticals Inc | NON_COMPLIANT | 0.25% | AAOIFI21.0% Usmani67.5% Dow Jones Islamic23.0% S&P Shariah25.1% MSCI Islamic67.5% MSCI Islamic M-Series25.1% FTSE Shariah58.8% |
| 7666.HK Metis TechBio Co Ltd | NON_COMPLIANT | 0.24% | AAOIFI0.9% Usmani17.2% Dow Jones Islamicfail S&P Shariahfail MSCI Islamic10.2% MSCI Islamic M-Seriesfail FTSE Shariah10.2% |
| BRIGHT PEAK THERAPEUTICS INC | UNSCREENED | 0.22% | no in-house ratios for this holding |
| SGMT Sagimet Biosciences Inc | NON_COMPLIANT | 0.22% | AAOIFI0.3% Usmani0.7% Dow Jones Islamic1.0% S&P Shariah1.2% MSCI Islamic0.7% MSCI Islamic M-Series1.2% FTSE Shariah0.0% |
| Bright Minds Biosciences Inc | UNSCREENED | 0.21% | no in-house ratios for this holding |
| ZEAL.CO Zealand Pharma A/S | NON_COMPLIANT | 0.19% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| KARTOS THERAPEUTICS INC | UNSCREENED | 0.19% | no in-house ratios for this holding |
| BridgeBio Oncology Therapeutics Inc | UNSCREENED | 0.19% | no in-house ratios for this holding |
| Denali Therapeutics Inc | UNSCREENED | 0.19% | no in-house ratios for this holding |
| Avalo Therapeutics Inc | UNSCREENED | 0.19% | no in-house ratios for this holding |
| Vaxcyte Inc | UNSCREENED | 0.18% | no in-house ratios for this holding |
| TNGX Tango Therapeutics Inc | NON_COMPLIANT | 0.18% | AAOIFI0.7% Usmani3.0% Dow Jones Islamic1.9% S&P Shariah2.3% MSCI Islamic3.0% MSCI Islamic M-Series2.3% FTSE Shariah0.0% |
| Aktis Oncology Inc | UNSCREENED | 0.18% | no in-house ratios for this holding |
| BMRN BioMarin Pharmaceutical Inc | NON_COMPLIANT | 0.17% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| Dyne Therapeutics Inc | UNSCREENED | 0.17% | no in-house ratios for this holding |
| GLUE Monte Rosa Therapeutics Inc | NON_COMPLIANT | 0.16% | AAOIFI4.3% Usmani5.5% Dow Jones Islamic4.5% S&P Shariah5.9% MSCI Islamic5.5% MSCI Islamic M-Series5.9% FTSE Shariah0.0% |
| GKOS Glaukos Corp | COMPLIANT | 0.16% | AAOIFI0.9% Usmani17.3% Dow Jones Islamic1.4% S&P Shariah1.5% MSCI Islamic10.0% MSCI Islamic M-Series1.5% FTSE Shariah6.2% |
| UTHR United Therapeutics Corp | NON_COMPLIANT | 0.15% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| Scholar Rock Holding Corp | UNSCREENED | 0.15% | no in-house ratios for this holding |
| MIRVIE SERIES C | UNSCREENED | 0.15% | no in-house ratios for this holding |
| NUVB Nuvation Bio Inc | NON_COMPLIANT | 0.15% | AAOIFI10.5% Usmani33.9% Dow Jones Islamic18.7% S&P Shariah23.6% MSCI Islamic33.9% MSCI Islamic M-Series23.6% FTSE Shariah33.4% |
| KYMR Kymera Therapeutics Inc | NON_COMPLIANT | 0.15% | AAOIFI0.8% Usmani4.8% Dow Jones Islamic1.7% S&P Shariah2.1% MSCI Islamic4.6% MSCI Islamic M-Series2.1% FTSE Shariah0.0% |
| EIKN Eikon Therapeutics Inc | NON_COMPLIANT | 0.15% | AAOIFI42.9% Usmani32.4% Dow Jones Islamic— S&P Shariah— MSCI Islamic32.4% MSCI Islamic M-Series— FTSE Shariah0.0% |
| Bicara Therapeutics Inc | UNSCREENED | 0.15% | no in-house ratios for this holding |
| NUCLEIX LTD | UNSCREENED | 0.15% | no in-house ratios for this holding |
| IMNM Immunome Inc | NON_COMPLIANT | 0.14% | AAOIFI0.2% Usmani0.8% Dow Jones Islamic0.3% S&P Shariah0.4% MSCI Islamic0.8% MSCI Islamic M-Series0.4% FTSE Shariah0.0% |
| 4568.T Daiichi Sankyo Co Ltd | COMPLIANT | 0.14% | AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| RARE Ultragenyx Pharmaceutical Inc | NON_COMPLIANT | 0.14% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| CELLARITY INC | UNSCREENED | 0.13% | no in-house ratios for this holding |
| MAZE Maze Therapeutics Inc | COMPLIANT | 0.12% | AAOIFI4.2% Usmani11.4% Dow Jones Islamicfail S&P Shariahfail MSCI Islamic11.4% MSCI Islamic M-Seriesfail FTSE Shariah7.3% |
| INSITRO INC | UNSCREENED | 0.12% | no in-house ratios for this holding |
| KLRA Kailera Therapeutics Inc | NON_COMPLIANT | 0.11% | AAOIFI0.5% Usmani0.8% Dow Jones Islamic— S&P Shariah— MSCI Islamic0.8% MSCI Islamic M-Series— FTSE Shariah0.0% |
| NGNE Neurogene Inc | NON_COMPLIANT | 0.11% | AAOIFI1.1% Usmani3.4% Dow Jones Islamic2.2% S&P Shariah2.5% MSCI Islamic3.4% MSCI Islamic M-Series2.5% FTSE Shariah0.0% |
| Definium Therapeutics Inc | UNSCREENED | 0.10% | no in-house ratios for this holding |
| EYPT EyePoint Inc | NON_COMPLIANT | 0.10% | AAOIFIfail Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail |
| ORIC ORIC Pharmaceuticals Inc | COMPLIANT | 0.10% | AAOIFI0.3% Usmani0.8% Dow Jones Islamic0.4% S&P Shariah0.4% MSCI Islamic0.8% MSCI Islamic M-Series0.4% FTSE Shariah0.0% |
| 9926.HK Akeso Inc | NON_COMPLIANT | 0.10% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| 22UA.DE BioNTech SE | NON_COMPLIANT | 0.10% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| GOLDFINCH BIO INC | UNSCREENED | 0.09% | no in-house ratios for this holding |
| Enanta Pharmaceuticals Inc | UNSCREENED | 0.09% | no in-house ratios for this holding |
| RGNX REGENXBIO Inc | NON_COMPLIANT | 0.09% | AAOIFI11.7% Usmani17.8% Dow Jones Islamic14.0% S&P Shariah12.0% MSCI Islamic17.8% MSCI Islamic M-Series12.0% FTSE Shariah0.0% |
| NUCLEIX LTD | UNSCREENED | 0.09% | no in-house ratios for this holding |
| Summit Therapeutics Inc | UNSCREENED | 0.09% | no in-house ratios for this holding |
| MLTX MoonLake Immunotherapeutics | NON_COMPLIANT | 0.08% | AAOIFI8.0% Usmani17.7% Dow Jones Islamic4.2% S&P Shariah3.6% MSCI Islamic17.7% MSCI Islamic M-Series3.6% FTSE Shariah17.3% |
| Kodiak Sciences Inc | UNSCREENED | 0.08% | no in-house ratios for this holding |
| CTMX CytomX Therapeutics Inc | NON_COMPLIANT | 0.08% | AAOIFI0.7% Usmani1.5% Dow Jones Islamic1.3% S&P Shariah1.8% MSCI Islamic1.5% MSCI Islamic M-Series1.8% FTSE Shariah0.0% |
| VOR Vor BioPharma Inc | NON_COMPLIANT | 0.07% | AAOIFI0.3% Usmani0.6% Dow Jones Islamic0.9% S&P Shariah1.2% MSCI Islamic0.6% MSCI Islamic M-Series1.2% FTSE Shariah0.0% |
| Arvinas Inc | UNSCREENED | 0.07% | no in-house ratios for this holding |
| EXO IMAGING INC | UNSCREENED | 0.07% | no in-house ratios for this holding |
| MPLT MapLight Therapeutics Inc | NON_COMPLIANT | 0.07% | AAOIFI0.3% Usmani0.5% Dow Jones Islamic— S&P Shariah— MSCI Islamic0.5% MSCI Islamic M-Series— FTSE Shariah0.0% |
| OCUL Ocular Therapeutix Inc | NON_COMPLIANT | 0.07% | AAOIFI0.3% Usmani1.0% Dow Jones Islamic0.4% S&P Shariah0.5% MSCI Islamic1.0% MSCI Islamic M-Series0.5% FTSE Shariah0.0% |
| Allogene Therapeutics Inc | UNSCREENED | 0.07% | no in-house ratios for this holding |
| Biohaven Ltd | UNSCREENED | 0.06% | no in-house ratios for this holding |
| KARTOS THERAPEUTICS INC | UNSCREENED | 0.06% | no in-house ratios for this holding |
| AFFINIVAX INC | UNSCREENED | 0.06% | no in-house ratios for this holding |
| WVE WaVe Life Sciences Ltd | NON_COMPLIANT | 0.05% | AAOIFI3.9% Usmani7.8% Dow Jones Islamic2.9% S&P Shariah3.6% MSCI Islamic7.8% MSCI Islamic M-Series3.6% FTSE Shariah0.0% |
| FDMT 4D Molecular Therapeutics Inc | NON_COMPLIANT | 0.05% | AAOIFI4.7% Usmani8.0% Dow Jones Islamic9.8% S&P Shariah6.8% MSCI Islamic8.0% MSCI Islamic M-Series6.8% FTSE Shariah4.0% |
| Syndax Pharmaceuticals Inc | UNSCREENED | 0.05% | no in-house ratios for this holding |
| TCRX TScan Therapeutics Inc | NON_COMPLIANT | 0.04% | AAOIFI342.5% Usmani53.0% Dow Jones Islamic192.2% S&P Shariah114.9% MSCI Islamic53.0% MSCI Islamic M-Series114.9% FTSE Shariah19.1% |
| UPB Upstream Bio Inc | NON_COMPLIANT | 0.04% | AAOIFI0.3% Usmani0.3% Dow Jones Islamic0.1% S&P Shariah— MSCI Islamic0.3% MSCI Islamic M-Series— FTSE Shariah0.0% |
| CRVS Corvus Pharmaceuticals Inc | COMPLIANT | 0.03% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| ABCURO SERIES B | UNSCREENED | 0.03% | no in-house ratios for this holding |
| NYXH Nyxoah SA | NON_COMPLIANT | 0.02% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| ANNX Annexon Inc | COMPLIANT | 0.02% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| AMUNIX INC | UNSCREENED | 0.02% | no in-house ratios for this holding |
| CONTRA ABIOMED INC | UNSCREENED | 0.01% | no in-house ratios for this holding |
| CONTRA MIRATI THERAPEU | UNSCREENED | 0.01% | no in-house ratios for this holding |
| ABCURO SERIES C EQUITY | UNSCREENED | 0.01% | no in-house ratios for this holding |
| CONTRA BLUEPRINT MEDIC | UNSCREENED | 0.00% | no in-house ratios for this holding |
| GOSS Gossamer Bio Inc | NON_COMPLIANT | 0.00% | AAOIFI4.6% Usmani5.1% Dow Jones Islamic1.3% S&P Shariah1.5% MSCI Islamic5.1% MSCI Islamic M-Series1.5% FTSE Shariah0.0% |
| EXO IMAGING INC | UNSCREENED | 0.00% | no in-house ratios for this holding |
| CONTRA VIGIL NEUROSCIE | UNSCREENED | 0.00% | no in-house ratios for this holding |
| SWIFT HEALTH SYSTEMS INC | UNSCREENED | 0.00% | no in-house ratios for this holding |
| CONTRA ARCELLX INC | UNSCREENED | 0.00% | no in-house ratios for this holding |
| CONTRA HOLOGIC INCORPO | UNSCREENED | 0.00% | no in-house ratios for this holding |
| GOLDFINCH EQUITY WARRANTS | UNSCREENED | 0.00% | no in-house ratios for this holding |
| CONTRA FREQUENCY THERA | UNSCREENED | 0.00% | no in-house ratios for this holding |
The published standards disagree about this fund by 26 points of portfolio weight — 53.7% of it passes AAOIFI, 27.7% passes MSCI Islamic. Which number is yours depends on which standard you follow.
These bars are the financial-ratio result under each standard — debt, receivables and interest income. They do not screen what the business does, so a holding can pass every ratio here and still be questionable or non-compliant on activity. The blended verdict above accounts for both.
ratios pass on 53.7% ratios fail on 14.9% 31.7% not rated under AAOIFI
ratios pass on 32.3% ratios fail on 33.7% 34.4% not rated under Usmani
ratios pass on 46.7% ratios fail on 18.8% 34.8% not rated under Dow Jones Islamic
ratios pass on 49.7% ratios fail on 14.7% 35.9% not rated under S&P Shariah
ratios pass on 27.7% ratios fail on 37.6% 35.1% not rated under MSCI Islamic
ratios pass on 49.5% ratios fail on 16.0% 34.9% not rated under MSCI Islamic M-Series
ratios pass on 31.9% ratios fail on 31.9% 36.6% not rated under FTSE Shariah
98 of 175 listed holdings carry our own per-methodology verdicts (75% of weight). The rest hold a provider verdict with no methodology breakdown, and are counted as rated by none. Of those, 76 (61% of weight) also carry the underlying debt ratio; the rest show a verdict without the figure behind it.
| Non-compliant holding | Weight |
|---|---|
| MRNA Moderna Inc | 3.57% |
| CYTK Cytokinetics Inc | 1.29% |
| UNH UnitedHealth Group Inc | 1.27% |
| IMCR Immunocore Holdings PLC | 1.06% |
| RYTM Rhythm Pharmaceuticals Inc | 1.05% |
| PFE Pfizer Inc | 0.99% |
| BMY Bristol-Myers Squibb Co | 0.95% |
| IQV IQVIA Holdings Inc | 0.84% |
| PTGX Protagonist Therapeutics Inc | 0.78% |
| KLRA KAILERA THERAPEUTICS INC | 0.51% |
Methodology breakdown computing — it will appear here on its own.
Trade setup
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
Why this signal?
The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.
BlackRock Health Sciences Term Trust (BMEZ) is currently considered not halal (non-compliant), per our own look-through to its filed holdings. See its filed holdings and the weight breakdown below for the reasoning.
🕌 In-house Compliance Research
Computing the full ratio and business-activity breakdown for BMEZ — this runs off the critical path so the page paints first. It will appear here on its own.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
Price Forecast
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Technical Summary
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Every indicator, and what it reads
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 69.70 | NEUTRAL |
| Stochastic %K (14) | 99.34 | SELL |
| CCI (20) | 222.63 | SELL |
| Williams %R (14) | -0.66 | SELL |
| MACD (12,26,9) | 0.11 | BUY |
| ROC (10) | 8.46 | BUY |
| Momentum (10) | 1.37 | BUY |
| EMA (10) | 16.92 | BUY |
| SMA (10) | 16.83 | BUY |
| EMA (20) | 16.72 | BUY |
| SMA (20) | 16.57 | BUY |
| EMA (30) | 16.62 | BUY |
| SMA (30) | 16.59 | BUY |
| EMA (50) | 16.40 | BUY |
| SMA (50) | 16.58 | BUY |
| EMA (100) | 15.86 | BUY |
| SMA (100) | 15.76 | BUY |
| EMA (200) | 15.10 | BUY |
| SMA (200) | 14.79 | BUY |
Weak — low conviction, small size or skip
SMC — Top Down
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | BULLISH | 42 |
| ⏰ 4H | BULLISH | 29 |
| 🕐 1H | BULLISH | 98 |
| ⏱ 15-Min | BULLISH | 130 |
| ⏲ 5-Min | BULLISH | 234 |
Momentum & Volume
Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.
Peer Movement
How the rest of the sector moved over the same window. Context for a price move, never a cause of one.
Peer movement computing — it will appear here on its own.
Before you act on this
The questions worth asking about any verdict on this page, answered plainly.
Is a fund screened on its name?
No. HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A fund marketed as Islamic still gets the same look-through as any other.
What does unrated weight mean?
It is the share of the fund whose holdings HTR cannot cover far enough to rate. It is reported as unrated rather than counted as compliant, because a holding nobody screened should not look like one that passed.
Does the issuer's board make it compliant?
It matters, and it is noted, but it does not replace the look-through. The board's judgement and the holdings screen are shown separately so you can see when they agree and when they do not.
How often is this re-screened?
When the fund files new holdings, and on a rolling basis besides. The date on the verdict above is the last time this fund was actually recomputed.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Compare with
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Insider Activity (90d)
Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.
NO DATA 0 buys · 0 sells
COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE
The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.
NEUTRAL report date 2026-10-20 · Asset managers net 901377 (-14458)
AI Summary
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.